Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine. (Q48943157)

17 February 2018

title

Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine. (English)

1 reference

17 February 2018

0 references

1

1 reference

17 February 2018

Raffaella Molteni

2

1 reference

17 February 2018

Marco A. Riva

6

1 reference

17 February 2018

author name string

Cecilia Gabriel

3

1 reference

17 February 2018

Elisabeth Mocaer

4

1 reference

17 February 2018

Giorgio Racagni

5

1 reference

17 February 2018

publication date

22 December 2010

1 reference

17 February 2018

published in

Psychopharmacology

1 reference

17 February 2018

volume

215

1 reference

17 February 2018

issue

2

1 reference

17 February 2018

page(s)

267-275

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-010-2129-8

exact match

0 references

cites work

Mouse and rat BDNF gene structure and expression revisited

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

New selective ligands of human cloned melatonin MT1 and MT2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

New approaches to antidepressant drug discovery: beyond monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

BDNF and trkB mRNAs oscillate in rat brain during the light-dark cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Hippocampal changes in patients with a first episode of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Is it time to reassess the BDNF hypothesis of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

At least four distinct circadian regulatory mechanisms are required for all phases of rhythms in mRNA amount

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

New insights into BDNF function in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Basal and stress-induced modulation of activity-regulated cytoskeletal associated protein (Arc) in the rat brain following duloxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Could agomelatine be the ideal antidepressant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Effect of agomelatine in the chronic mild stress model of depression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Emerging role of the FGF system in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Untreated Depression and Hippocampal Volume Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

The fibroblast growth factor system and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2129-8

Effects of early visual experience and diurnal rhythms on BDNF mRNA and protein levels in the visual system, hippocampus, and cerebellum.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21181122

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neuronal plasticity: a link between stress and mood disorders

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21181122

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21181122

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00213-010-2129-8

1 reference

17 February 2018

1 reference

17 February 2018